Summary
Karim Ghoufiri
Business developper
Technology
- The project developers have devised a groundbreaking technology involving the integration of a prism into a contact lens. This innovative approach aims to deviate the optical axis, presenting a novel avenue in treating conditions like macular degeneration. By retraining patients to realign their gaze effortlessly, this innovation seeks to minimize ocular fatigue while also serving a preventative purpose.
Market
- The technology is intended for both Dry Age-Related Macular Degeneration (AMD) and Wet Age-Related Macular Degeneration (AMD).
Development status
- At the moment, there are ongoing studies focusing on the localization of the intact zones within the retina. The prototype’s design does not exist and there’s a need to validate certain characteristics before finalization
IP
- Patent pending PCT
- IB2024/000068 – 2024/02/13
- First positive written opinion issued by the EPO
Valorisation strategy
- Licensing